Metabolic effects of the atypical antipsychotics

Southern Medical Journal

Volumn 100, Issue 8, 2007, Pages 771-772

  Wooten, James ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; INSULIN; NEUROLEPTIC AGENT; OLANZAPINE; ORAL ANTIDIABETIC AGENT; QUETIAPINE; RISPERIDONE; TIOTIXENE; ZIPRASIDONE;

BIPOLAR MANIA; CLINICAL RESEARCH; DRUG SAFETY; DYSLIPIDEMIA; EDITORIAL; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN TREATMENT; MENTAL DISEASE; OBESITY; PRIMARY MEDICAL CARE; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; DIABETES MELLITUS; DIBENZOTHIAZEPINES; DYSLIPIDEMIAS; GLUCOSE METABOLISM DISORDERS; HUMANS; INSULIN RESISTANCE; MENTAL DISORDERS; OBESITY; PHENOTHIAZINES; PIPERAZINES; QUINOLONES; RISPERIDONE; SCHIZOPHRENIA; THIAZOLES;

EID: 34548394992     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e318063e8ef     Document Type: Editorial

References (6)

1. Food and Drug Administration Center for Drug Evaluation and Research. Available at http://www.fda.gov/cder/index.html. Accessed April 23, 2007.
2. Available at http://www.nytimes.com/aponline/business/AP-Eli-Lilly-Pill. html?_r=2&oref=slogin&oref=slogin. Accessed December 18, 2006.
3. Llorente MD, Urrutia V. Diabetes, psychiatric disorders and the metabolic effects of antipsychotic medications. Clin Diabetes 2006;24:18-24.
4. McNeely MJ. Case study: atypical antipsychotic use associated with severe hyperglycemia. Clin Diabetes 2002;2:195-196.
5. Poulin MJ, Cortese L, Williams R, et al. Atypical antipsychotics in psychiatric practice: practical implications for clinical monitoring. Can J Psychiatry 2005;50:555-562.
6. Ananth J, Venkatesh R, Burgoyne K, et al. Atypical antipsychotic drug use and diabetes. Psychother Psychosom 2002;71:244-254.